Original Research
Accepted on 29 Dec 2025
Dual blockade of DPP-4 and CXCL12/CXCR4 axes synergistically protects podocytes in lupus nephritis
in Renal Pharmacology
Frontiers in Pharmacology
Type at least 3 characters
724 articles
articles
Original Research
Accepted on 23 Dec 2025
Insulin Restores Renal Neprilysin (NEP) and Attenuates the Shedding of Urinary NEP and KIM-1 in Diabetic Akita Mice
in Renal Pharmacology
Frontiers in Pharmacology
- 109 views
General Commentary
Accepted on 22 Dec 2025
Commentary: Effect of injecting adipose stem cells combined with platelet-rich fibrin releasate at Shenshu acupoint (BL23) on acute kidney injury in rabbits
in Renal Pharmacology
Frontiers in Pharmacology
Original Research
Accepted on 19 Dec 2025
Hyperoside ameliorates lupus nephritis by suppressing AKT1-mediated PANoptosis in podocytes: integrating network pharmacology and experimental validation
in Renal Pharmacology
Frontiers in Pharmacology
- 155 views
Original Research
Published on 18 Dec 2025
Impact of postoperative flurbiprofen axetil on renal function in spontaneously hypertensive rats
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1686334
- 540 views
Original Research
Published on 18 Dec 2025
Nanozyme-armored natural enzymes for acute kidney injury management via inflammation regulation and oxidative damage mitigation
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1686323
- 323 views
Original Research
Published on 18 Dec 2025
Therapeutic trough mycophenolic acid levels positively correlate with omega-3 fatty acids in leukocytes of children with idiopathic nephrotic syndrome. a pilot study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1672304
- 310 views
Review
Published on 18 Dec 2025
Molecular mechanisms and multi-target therapeutic strategies of diabetic nephropathy: from pathogenesis to precision interventions
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1729941
- 419 views
Review
Accepted on 17 Dec 2025
Roxadustat for renal anemia: current clinical experience
in Renal Pharmacology
Frontiers in Pharmacology
- 273 views
Original Research
Accepted on 15 Dec 2025
A new Jun amino terminal kinase inhibitor, KRev-202, inhibits ischaemic acute kidney injury and the progression to renal fibrosis in the rat
in Renal Pharmacology
Frontiers in Pharmacology
Correction
Published on 15 Dec 2025
Correction: Mitochondrial iron overload-mediated inhibition of Nrf2-HO-1/GPX4 assisted ALI-induced nephrotoxicity
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1734058
- 276 views
Editorial
Published on 12 Dec 2025
Editorial: Cell death in kidney diseases: novel biomarkers, mechanisms, and therapeutic strategies
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1715728
- 510 views
Correction
Accepted on 11 Dec 2025
Correction: Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway
in Renal Pharmacology
Frontiers in Pharmacology
- 107 views
Review
Published on 03 Dec 2025
Advances in ginsenoside treatment for common kidney diseases: pharmacological evaluation and potential mechanisms
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1702234
- 1,090 views
Review
Accepted on 30 Nov 2025
Improving kidney transplantation by pharmacological addition of the hypothermic preservation solution: a scoping review
in Renal Pharmacology
Frontiers in Pharmacology
- 202 views
Original Research
Accepted on 24 Nov 2025
High glucose induced PLCG1 histone acetylation to promote ferroptosis by LAMP2A/ HSPA8 in model of Diabetic nephropathy
in Renal Pharmacology
Frontiers in Pharmacology
- 156 views
Review
Accepted on 24 Nov 2025
Unraveling the Role of Mitochondrial Dysfunction in Diabetic Kidney Disease: Insights and Interventions
in Renal Pharmacology
Frontiers in Pharmacology
- 228 views
Review
Published on 21 Nov 2025
Licorice in nephropathy treatment: phytochemical compositions and pharmacological mechanisms
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1672643
- 1,158 views
Original Research
Published on 19 Nov 2025
Comparative effectiveness and pharmacological fingerprints of indobufen versus rivaroxaban in patients with chronic kidney disease: a single-center, real-world study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1694163
- 760 views
Review
Published on 18 Nov 2025
Comparison of short-term and long-term renal function effects of vasopressin and norepinephrine in patients with septic shock: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1669636
- 927 views
Original Research
Published on 18 Nov 2025
In vivo pharmacokinetic evaluation of molnupiravir in patients with severe chronic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1696197
- 710 views
Systematic Review
Published on 14 Nov 2025
Effect of intravitreal VEGF inhibitors on renal-related adverse events in patients with diabetes mellitus: systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1691597
- 988 views
Review
Published on 13 Nov 2025
Immunomodulatory roles of quercetin in diabetic nephropathy: targeting inflammation, oxidative stress, and ferroptosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1687677
- 1,470 views
Correction
Published on 12 Nov 2025
Correction: Renoprotective effects of GHRH agonist MR409 is associated with reduced oxidative stress and ferroptosis in diabetic mice
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1737333
- 424 views